M.E., H. N., E., G., A.D., B., A., K., J., Z., J., S., . . . J.C., B. (2021). Integrative sequencing discovers an ATF1-motif enriched molecular signature that differentiates hyalinizing clear cell carcinoma from mucoepidemoid carcinoma. Oral Oncol.
Chicago Style CitationM.E., Heft Neal, et al. "Integrative Sequencing Discovers an ATF1-motif Enriched Molecular Signature That Differentiates Hyalinizing Clear Cell Carcinoma From Mucoepidemoid Carcinoma." Oral Oncol 2021.
Cita MLAM.E., Heft Neal, et al. "Integrative Sequencing Discovers an ATF1-motif Enriched Molecular Signature That Differentiates Hyalinizing Clear Cell Carcinoma From Mucoepidemoid Carcinoma." Oral Oncol 2021.
Atenció: Aquestes cites poden no estar 100% correctes.